Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5425
+0.0425 (8.50%)
At close: Nov 19, 2026, 4:00 PM EST
0.5409
-0.0016 (-0.29%)
After-hours: Nov 19, 2026, 7:58 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $150.71 million as of November 19, 2026. It is the 21,904th most valuable company in the world and the 3,697th biggest in the United States. Its market cap has decreased by 32.94% in one year.
Market Cap
150.71M
Enterprise Value
153.36M
1-Year Change
-32.94%
Global Rank
Country Rank
#3,697 United States
Category
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $150.71M, an increase of 21.24%. That is a compound annual growth rate of 3.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 150.71M | -18.70% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 148.08M |
| Veraxa Biotech AG | 147.06M |
| Zentalis Pharmaceuticals | 146.42M |
| Protara Therapeutics | 142.84M |
| Atrium Therapeutics | 139.78M |
| Sionna Therapeutics | 138.87M |
| Jyong Biotech | 133.62M |
| PolyPid | 132.84M |